In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $1.52 in the prior trading day, SELLAS Life Sciences Group Inc (NASDAQ: SLS) closed at $1.46, down -3.95%. In other words, the price has decreased by -$3.95 from its previous closing price. On the day, 1.28 million shares were traded. SLS stock price reached its highest trading level at $1.545 during the session, while it also had its lowest trading level at $1.4217.
Ratios:
Our goal is to gain a better understanding of SLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.23 and its Current Ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 82150848 and an Enterprise Value of 80526800.
Stock Price History:
The Beta on a monthly basis for SLS is 2.19, which has changed by -0.02013421 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, SLS has reached a high of $1.91, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 23.00%, while the 200-Day Moving Average is calculated to be 24.02%.
Shares Statistics:
The stock has traded on average 1.47M shares per day over the past 3-months and 1285940 shares per day over the last 10 days, according to various share statistics. A total of 56.27M shares are outstanding, with a floating share count of 55.88M. Insiders hold about 0.69% of the company’s shares, while institutions hold 9.89% stake in the company. Shares short for SLS as of 1713139200 were 5666163 with a Short Ratio of 3.87, compared to 1710460800 on 5179937. Therefore, it implies a Short% of Shares Outstanding of 5666163 and a Short% of Float of 10.08.
Earnings Estimates
The current rating of SELLAS Life Sciences Group Inc (SLS) is the result of assessments by 3.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.16 and a low estimate of -$0.25, while EPS last year was -$0.47. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.16 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.6 and -$1.15 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.85, with 4.0 analysts recommending between -$0.5 and -$1.28.
